Skip to content

The Effect of Lavender Aromatherapy on Cognitive Function in Older Adults With Mild Cognitive Impairment

The Effect of Lavender Aromatherapy on Cognitive Function in Older Adults With Mild Cognitive Impairment

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07688382
Enrollment
70
Registered
2026-07-07
Start date
2026-09-01
Completion date
2027-01-02
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MCI

Brief summary

1. To analyze the therapeutic effects of lavender aromatherapy on memory function and overall cognitive function in older adults with Mild Cognitive Impairment (MCI); 2. To analyze whether lavender aromatherapy improves executive function, language ability, attention, visuospatial ability, anxiety, depression, quality of life, and sleep in older adults with MCI.

Detailed description

The intervention protocol was established as follows: Based on the elderly participant's usual bedtime, the time of going to bed was recorded. The participant was instructed to assume a comfortable sleeping position, use the graduated dropper provided with the essential oil bottle to measure 0.15 ml (approximately 3 drops; theoretically, 0.05 ml per drop) of diluted lavender essential oil, and drip it vertically onto the upper center of a cotton pad. The cotton pad was then pinned to the collar with a safety pin, and the participant was instructed to inhale the scent evenly for 30 minutes. Afterward, the intervention staff or caregiver will remove the cotton pad. The intervention will be conducted 5 days a week for 12 weeks.

Interventions

OTHERaromatherapy

Participants in the intervention group will receive aromatherapy inhalation for 30 minutes per session, five times a week, over a period of 12 week

Sponsors

China Medical University, China
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

1. The MCI mentioned in this study meets the diagnostic criteria proposed by the \*Chinese Expert Consensus on the Diagnosis and Treatment of Alzheimer's Disease-Derived Mild Cognitive Impairment (2021)\*: cognitive impairment reported by the patient or an informant, or identified by an experienced clinician; objective evidence of impairment in one or more cognitive domains, with episodic memory impairment being the most common; complex instrumental activities of daily living may be mildly impaired, but the ability to perform basic activities of daily living remains independent; the diagnostic criteria for dementia are not met. 2. MoCA-Beijing version scores were adjusted for education level: ≤13 for junior high school education or below, ≤19 for high school education, and ≤24 for university education or above; MMSE score \>24; ADL score \<23. 3. Age between 60 and 79 years. 4. Normal olfactory function assessed using the "Sniffin' Sticks" test. 5. Ability to communicate normally and complete cognitive assessments. 6. Residing in a senior care facility with no plans to leave within the next 12 weeks.

Exclusion criteria

1. Presence of other conditions known to affect cognitive function, such as psychiatric disorders (e.g., schizophrenia, depression). 2. History of asthma or any allergic conditions. 3. Use of any prescription medications that may impact cognitive function (including psychotropic drugs and others)

Design outcomes

Primary

MeasureTime frameDescription
Gobal cognitive functionWeek 12Use the Mini-Mental State Examination to assess overall cognitive function.
MemoryWeek 12Use the Auditory Verbal Learning Test to assess memory function.

Secondary

MeasureTime frameDescription
Language functionWeek 12Use the Boston Naming Test to assess Language function
Executive functionWeek 12Use the TMT-B to assess Executive function
Visual spaceWeek 12Use the Draw-a-Clock Test to assess Visual space
AttentionWeek 12Use the TMT-A to assess Attention
AnxietyWeek 12Use the 15-item Geriatric Depression Scale to assess Anxiety
DepressionWeek 12Use the 15-item Geriatric Depression Scale to assess Depression
Sleep QualityWeek 12Use the Pittsburgh Sleep Quality Index to assess Depression
Quality of Life assessWeek 12Use the ShortForm 8 Health Survey Questionnaire to assess Depression

Contacts

CONTACTYuxin Zhang, Graduate
18867845231@163.com18867845231
PRINCIPAL_INVESTIGATORYuxin Zhang, Graduate

China Medical University, China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026